Other News Releases in Cosmetics and Personal Care
Be Sensational with Maybelline New York, CVS/pharmacy and CHICAGO the musical
Fusion Brands Inc. Signs Kim Kardashian as the Face of Fusion Beauty Colorceuticals' LipFusion Franchise and New Illumifill Line Filling Luminizer
The Kardashian Sisters Finally Reveal Their Secret for Perfect Skin
Other News Releases in Surveys, Polls and Research
New Data Demonstrates Abbott's Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition
Abbott Statement: ACCORD Lipid Results Support Treatment Guidelines for Fibrate Use
U.S. Census Bureau Daily Feature for March 14
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
See more news releases in: Cosmetics and Personal Care, Household, Consumer & Cosmetics, Publishing & Information Services, Health Care & Hospitals, Medical Pharmaceuticals, Mental Health, Surveys, Polls and Research
Botulinum Toxins Such as Botox and Dysport May Offer Price Effective Treatments for Depression
WEST PALM BEACH, Fla., Jan. 4 /PRNewswire/ -- According to an article in the January 2010 edition of Drugs In Dermatology (abstract available at http://jddonline.com ), the use of botulinum type A toxins such as Botox and Dysport may offer a cost efficient alternative to the use of selective serotonin reuptake inhibitors. Kenneth Beer MD, who authored the article, says that he began to consider the possibility that injections of Botox and Dysport might be cost effective after reading an article by Finzi et al published in the Journal of Dermatologic Surgery. Dr. Beer then began to notice that many of his patients began to feel better after they started to look better.
According to Dr. Beer, "So many people take medications for depression that I wondered whether injections with type A botulinum toxins could offer them a better alternative. I collected some very preliminary data comparing the costs of each of the therapies and was surprised at the results."
Dr. Beer cautions that this report needs to be validated with a larger study and he hopes that such a trial will be initiated under the auspices of the National Institute for Mental Health.
SOURCE Kenneth Beer MD
Back to topRELATED LINKS
http://www.palmbeachcosmetic.com